Aileron Therapeutics, Inc.
ALRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$62,883 | -$15,732 | -$27,329 | -$26,164 |
| Dep. & Amort. | $63 | $119 | $169 | $121 |
| Deferred Tax | -$1,554 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,117 | $1,190 | $2,083 | $2,260 |
| Change in WC | $0 | -$5,381 | $420 | $242 |
| Other Non-Cash | $0 | -$4 | -$208 | -$213 |
| Operating Cash Flow | -$22,291 | -$19,808 | -$24,865 | -$23,754 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$157 |
| Net Acquisitions | $0 | -$96 | $0 | $66 |
| Inv. Purchases | $0 | $0 | -$21,850 | -$73,577 |
| Inv. Sales/Matur. | $0 | $16,250 | $48,309 | $37,751 |
| Other Inv. Act. | $0 | $42 | $26 | -$36 |
| Investing Cash Flow | $0 | $16,196 | $26,459 | -$35,917 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $10,645 | $0 | $0 | $55,583 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7,173 | $15,794 | $0 | $74 |
| Financing Cash Flow | $17,818 | $15,794 | $0 | $55,657 |
| Forex Effect | $0 | -$63 | $0 | $0 |
| Net Chg. in Cash | -$4,473 | $12,119 | $1,594 | -$4,014 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17,338 | $5,219 | $3,625 | $7,639 |
| End Cash | $12,865 | $17,338 | $5,219 | $3,625 |
| Free Cash Flow | -$22,291 | -$19,808 | -$24,865 | -$23,911 |